Role of levosimendan in sepsis and septic shock

作者: Bernardo Bollen Pinto , Sebastian Rehberg , Christian Ertmer , Martin Westphal

DOI: 10.1097/ACO.0B013E3282F43C56

关键词:

摘要: Purpose of reviewTo present the pharmacologic and biologic profile levosimendan discuss potential indications in treatment sepsis septic shock, with a special focus on myocardial pulmonary dysfunction.Recent findingsIn animal models endotoxic improved bot

参考文章(81)
François Kerbaul, Vlad Gariboldi, Roch Giorgi, Choukri Mekkaoui, Régis Guieu, Pierre Fesler, François Gouin, Serge Brimioulle, Frédéric Collart, Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure. Critical Care Medicine. ,vol. 35, pp. 1948- 1954 ,(2007) , 10.1097/01.CCM.0000275266.33910.8D
Andrea Morelli, Jean-Louis Teboul, Salvatore Maurizio Maggiore, Antoine Vieillard-Baron, Monica Rocco, Giorgio Conti, Andrea De Gaetano, Umberto Picchini, Alessandra Orecchioni, Iacopo Carbone, Luigi Tritapepe, Paolo Pietropaoli, Martin Westphal, Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Critical Care Medicine. ,vol. 34, pp. 2287- 2293 ,(2006) , 10.1097/01.CCM.0000230244.17174.4F
Markku S. Nieminen, Juha Akkila, Gerd Hasenfuss, Franz X. Kleber, Lasse A. Lehtonen, Veselin Mitrovic, Olof Nyquist, Willem J. Remme, Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. Journal of the American College of Cardiology. ,vol. 36, pp. 1903- 1912 ,(2000) , 10.1016/S0735-1097(00)00961-X
Martin Westphal, Andrea Morelli, Hugo Van Aken, Dear levosimendan, the right ventricle will thank you! Critical Care Medicine. ,vol. 35, pp. 952- 953 ,(2007) , 10.1097/01.CCM.0000257238.75346.DB
Saila Antila, Matti Kivikko, Lasse Lehtonen, Jaan Eha, Aira Heikkila, Pasi Pohjanjousi, Pertti J. Pentikainen, Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan. British Journal of Clinical Pharmacology. ,vol. 57, pp. 412- 415 ,(2004) , 10.1111/J.1365-2125.2003.02043.X
Alain Rudiger, Mervyn Singer, Mechanisms of sepsis-induced cardiac dysfunction Critical Care Medicine. ,vol. 35, pp. 1599- 1608 ,(2007) , 10.1097/01.CCM.0000266683.64081.02
Bracken J. De Witt, Ikhlass N. Ibrahim, Erin Bayer, Aaron M. Fields, Todd A. Richards, Ronald E. Banister, Alan D. Kaye, An analysis of responses to levosimendan in the pulmonary vascular bed of the cat. Anesthesia & Analgesia. ,vol. 94, pp. 1427- 1433 ,(2002) , 10.1097/00000539-200206000-00009
Matthias Lange, Andrea Morelli, Christian Ertmer, Katrin Br??king, Sebastian Rehberg, Hugo Van Aken, Daniel L. Traber, Martin Westphal, Role of adenosine triphosphate-sensitive potassium channel inhibition in shock states: physiology and clinical implications. Shock. ,vol. 28, pp. 394- 400 ,(2007) , 10.1097/SHK.0B013E318050C836
Reiko Takahashi, M. A. Hassan Talukder, Masao Endoh, Effects of OR-1896, an active metabolite of levosimendan, on contractile force and aequorin light transients in intact rabbit ventricular myocardium. Journal of Cardiovascular Pharmacology. ,vol. 36, pp. 118- 125 ,(2000) , 10.1097/00005344-200007000-00016